Craig Malzahn

Craig Malzahn

Company: REGENXBIO

Job title: Senior Vice President, Technical Operations

Seminars:

Reducing CoGs & Enhancing Manufacturing Efficiency for Gene Therapies 11:30 am

• Exploration of methods to lower CoGs through process improvements, automation, and scaling up production capabilities while ensuring consistent product quality for common disease • Examination of quality measures necessary to support manufacturing scalability, including potency assays, purity testing, and regulatory compliance • Insights from successful case studies and industry best practices in reducing CoGs…Read more

day: Focus Day

Panel Discussion: Breaking Boundaries: Navigating the Shift from Rare to Common Diseases in Gene Therapy 1:30 pm

• Exploring the unique challenges and benefits of expanding gene therapy into more prevalent conditions, including patient access, cost, and treatment scalability • Evaluating the feasibility of widespread gene therapy applications in common diseases by 2025, along with realistic goals and potential hurdles • Essential factors for successful translation, including regulatory preparedness, CMC adaptation, and…Read more

day: Focus Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.